Gujarat Themis Biosyn Board of Directors

Get the latest insights into the leadership at Gujarat Themis Biosyn. Learn about the experienced professionals guiding the company's strategy and governance.

NamePosition
Dr. Dinesh S Patel Non Executive Chairman
Dr. Sachin D Patel Managing Director
Mr. Hitesh D Gajaria Independent Director
Mr. K G Ananthakrishnan Independent Director
Mr. Nihar Parikh Independent Director
Mr. Siddharth Y Kusumgar Independent Director
Mrs. Kirandeep Kaur Madan Independent Director

Gujarat Themis Biosyn Share price

GUJTHEM

319.3

14.65 (-4.39%)
NSE
BSE
Last updated on 24 Feb, 2026 | 15:45 IST
alert_iconwatchlist_icon
BUYSELL
Today's High

331.90

Today's Low

316.00

52 Week Low

208.00

52 Week High

479.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Gujarat Themis Biosyn FAQs

The board at Gujarat Themis Biosyn consists of experienced professionals, including Dr. Dinesh S Patel , Dr. Sachin D Patel , and others, overseeing the company’s strategic and corporate governance.

Directors at Gujarat Themis Biosyn are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.

As of the latest update, Dr. Dinesh S Patel is the current chairman at Gujarat Themis Biosyn.

Executive directors at Gujarat Themis Biosyn are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.

Yes, Gujarat Themis Biosyn adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.

At Gujarat Themis Biosyn, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost